Genetic modifiers and ascertainment drive variable expressivity of complex disorders: group Reymond

Genetic modifiers and ascertainment drive variable expressivity of complex disorders: group Reymond

Matthew Jensen  1 Corrine Smolen  1 Anastasia Tyryshkina  1 Lucilla Pizzo  1 Jiawan Sun  1 Serena Noss  1 Deepro Banerjee  1 Matthew Oetjens  2 Hermela Shimelis  2 Cora M Taylor  2 Vijay Kumar Pounraja  1 Hyebin Song  3 Laura Rohan  1 Emily Huber  1 Laila El Khattabi  4 Ingrid van de Laar  5 Rafik Tadros  5 Connie R Bezzina  6 Marjon van Slegtenhorst  5 Janneke Kammeraad  5 Paolo Prontera  7 Jean-Hubert Caberg  8 Harry Fraser  9 Siddharth Banka  10 Anke Van Dijck  11 Charles Schwartz  12 Els Voorhoeve  13 Patrick Callier  14 Anne-Laure Mosca-Boidron  14 Nathalie Marle  14 Mathilde Lefebvre  14 Kate Pope  15 Penny Snell  15 Amber Boys  15 Paul J Lockhart  16 Myla Ashfaq  17 Elizabeth McCready  18 Margaret Nowacyzk  18 Lucia Castiglia  19 Ornella Galesi  19 Emanuela Avola  19 Teresa Mattina  20 Marco Fichera  21 Maria Grazia Bruccheri  19 Giuseppa Maria Luana Mandarà  22 Francesca Mari  23 Flavia Privitera  23 Ilaria Longo  23 Aurora Curró  23 Alessandra Renieri  23 Boris Keren  24 Perrine Charles  24 Silvestre Cuinat  25 Mathilde Nizon  25 Olivier Pichon  25 Claire Bénéteau  25 Radka Stoeva  26 Dominique Martin-Coignard  26 Sophia Blesson  27 Cedric Le Caignec  28 Sandra Mercier  25 Marie Vincent  25 Christa L Martin  2 Katrin Mannik  29 Alexandre Reymond  30 Laurence Faivre  31 Erik Sistermans  13 R Frank Kooy  11 David J Amor  16 Corrado Romano  21 Joris Andrieux  32 Santhosh Girirajan  33

Affiliations

Free article

Abstract

Variable expressivity of disease-associated variants implies a role for secondary variants that modify clinical features. We assessed the effects of modifier variants on the clinical outcomes of 2,455 individuals with primary variants. Among 124 families with the 16p12.1 deletion, distinct rare and common variant classes conferred risks for specific developmental features, including short tandem repeats for neurological defects. Network analysis suggested distinct mechanisms involving 16p12.1 genes and secondary variants specific to each proband. Within disease and population cohorts of 976 individuals with the 16p12.1 deletion, we found opposing effects of secondary variants on clinical features across ascertainments. Additional analysis of 1,479 probands with other primary variants, such as the 16p11.2 deletion and CHD8 variants, and 1,528 probands without primary variants showed that phenotypic associations differed by primary variant context and were influenced by synergistic interactions between primary and secondary variants. Our study provides a paradigm to dissect the personalized genomic architecture of complex disorders.

Keywords: ascertainment; autism spectrum disorder; complex disease; copy-number variants; modifiers; multi-hit model; neurodevelopmental; rare variants; variable expressivity.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Update of

  • Genetic modifiers and ascertainment drive variable expressivity of complex disorders. Jensen M, Smolen C, Tyryshkina A, Pizzo L, Banerjee D, Oetjens M, Shimelis H, Taylor CM, Pounraja VK, Song H, Rohan L, Huber E, El Khattabi L, van de Laar I, Tadros R, Bezzina C, van Slegtenhorst M, Kammeraad J, Prontera P, Caberg JH, Fraser H, Banka S, Van Dijck A, Schwartz C, Voorhoeve E, Callier P, Mosca-Boidron AL, Marle N, Lefebvre M, Pope K, Snell P, Boys A, Lockhart PJ, Ashfaq M, McCready E, Nowacyzk M, Castiglia L, Galesi O, Avola E, Mattina T, Fichera M, Bruccheri MG, Mandarà GML, Mari F, Privitera F, Longo I, Curró A, Renieri A, Keren B, Charles P, Cuinat S, Nizon M, Pichon O, Bénéteau C, Stoeva R, Martin-Coignard D, Blesson S, Le Caignec C, Mercier S, Vincent M, Martin C, Mannik K, Reymond A, Faivre L, Sistermans E, Kooy RF, Amor DJ, Romano C, Andrieux J, Girirajan S.medRxiv [Preprint]. 2024 Aug 28:2024.08.27.24312158. doi: 10.1101/2024.08.27.24312158. Update in: Cell. 2025 Oct 7:S0092-8674(25)01080-3. doi: 10.1016/j.cell.2025.09.012. PMID: 39252907Free PMC article.Preprint.

Similar articles

See all similar articles

Cited by

Related information

LinkOut – more resources

Information session dedicated to funding opportunities for postdoctoral fellowships and mobility, 27 Nov. 2025 (registration needed)

Dear colleagues,

The UNIL Research Service, in collaboration with the EPFL Research Office, is pleased to invite you to an information session dedicated to funding opportunities for postdoctoral fellowships and mobility.

Date: 27 November 2025
Time: 12:15 p.m. to 2:00 p.m.
Location:  in person, UNIL – Geopolis 1620

Topics will include:

·         Introduction and presentation of the UNIL Research Office
·         Databases of funding opportunities and alternative sources of support beyond SNSF and EU programmes
·         Marie Skłodowska-Curie Postdoctoral Fellowships (MSCA PF)
·         SNSF funding schemes
·         Q&A session with research funding experts from UNIL and EPFL

Presentations will be delivered in French, with slides in English. The Q&A session will be held in both French and English.

We warmly encourage all researchers considering a postdoctoral experience or international mobility to attend.

>> Registration

Meilleures salutations

Service de la recherche
UNIL | Université de Lausanne

Direction
Quartier UNIL- Sorge | Bâtiment Amphipôle
CH-1015 Lausanne |
Tél. +41 21 692 23 55
Tél (nccr) : +41 21 692 60 45

https://www.unil.ch/researcher/fr/home.html

CIG Seminars Fall 2025 Program

Monday 12:15, Génopode, auditorium B

Monday September 8, 2025 at 11:15 exceptionally
Murat Sünbül,
Heidelberg University, Heidelberg (DE)
«Designer RNAs to see biology in super-resolution»
Hosts: CIG PhD Students & Postdocs

Monday September 15, 2025
Gabriel Neurohr,
ETHZ, Zurich (CH)
«Size matters – Nuclear meltdown in senescence»
Host: Aleksandar Vjestica

Monday September 29, 2025
Eric Lai,
Memorial Sloan Kettering Cancer Center, New York (USA)
«MicroRNAs: from mechanisms to biology»
Host: Jean-Yves Roignant

Monday October 13, 2025
Manuel Irimia,
The Centre for Genomic Regulation, Barcelona (ES)
«Proteome specialization by cell type specific microexons in health, disease and evolution»
Host: Isabel Lopez Mejia

FRIDAY October 31, 2025
Olivia S. Rissland,
University of Colorado School of Medicine, Aurora (USA)
«The role of the coding region in regulating translation»
Host: David Gatfield

Monday December 8, 2025
Sylvie Retaux,
Institut des Neurosciences Paris‑Saclay (FR)
«The genetic basis of adaptive behaviors in blind cavefish»
Host: Johannes Larsch

Monday December 15, 2025
Andrés Bendesky,
Columbia University, New York (USA)
«The evolution of social behavior in nature and under domestication»
Host: Johannes Larsch